Lee John Sang 4
4 · PhaseBio Pharmaceuticals Inc · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Lee John Sang
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
[F1]2021-02-05+76,500→ 76,500 totalExercise: $4.31Exp: 2031-02-05→ Common Stock (76,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 5, 2021, subject to the reporting person's continued service through each such date.
Signature
/s/ John P. Sharp, Attorney-in-fact|2021-02-09